This compound is a pharmaceutical intermediate specifically designed as a precursor for the synthesis of 18F-L-Dopa, a radiolabeled compound used in positron emission tomography (PET) imaging for Parkinson's disease research. It features a protected catechol structure with tert-butyl ester and carbamate groups, along with a boronic ester moiety, which facilitates radiofluorination.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 2377146-66-0
Diethyl N-[4-(methylamino)benzoyl]-L-glutamate
pharmaceutical intermediate
Abiraterone N-Oxide
Abiraterone metabolite reference standard
(R)-(-)-2,2-Dimethyl-1,3-dioxolan-4-ylmethyl p-toluenesulfonate
Pharmaceutical intermediate for synthesis
4-Hydroxyindole
Precursor for psilocybin synthesis
tert-butyl (2S)-3-[4,5-bis(methoxymethoxy)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-2-[bis[(2-methylpropan-2-yl)oxycarbonyl]amino]propanoate
OMEJVTOXRPCWJF-QHCPKHFHSA-N
B1(OC(C(O1)(C)C)(C)C)C2=CC(=C(C=C2C[C@@H](C(=O)OC(C)(C)C)N(C(=O)OC(C)(C)C)C(=O)OC(C)(C)C)OCOC)OCOC